Rebound effect, the Glossary
The rebound effect, or rebound phenomenon, is the emergence or re-emergence of symptoms that were either absent or controlled while taking a medication, but appear when that same medication is discontinued, or reduced in dosage.[1]
Table of Contents
41 relations: Antidepressant, Antipsychotic, Antipsychotic switching, Anxiety, Anxiolytic, Benzodiazepine, Benzodiazepine withdrawal syndrome, Clobetasol propionate, Clonidine, Corticosteroid, COVID-19, Dextroamphetamine, Disuse supersensitivity, Dopamine supersensitivity psychosis, Drug withdrawal, Eszopiclone, Guanfacine, Hypnotic, Insomnia, Joe Biden, Major depressive disorder, Medication, Medication overuse headache, Methylphenidate, Nasal congestion, Nasal spray, Nirmatrelvir/ritonavir, Panic attack, Physical dependence, Psoriasis, Quazepam, Rhinitis medicamentosa, Sedative, Selective serotonin reuptake inhibitor, Signs and symptoms, Stimulant, Stimulant psychosis, Topical decongestant, Triazolam, Unintended consequences, Zolpidem.
- Psychiatric diagnosis
Antidepressant
Antidepressants are a class of medications used to treat major depressive disorder, anxiety disorders, chronic pain, and addiction.
See Rebound effect and Antidepressant
Antipsychotic
Antipsychotics, previously known as neuroleptics and major tranquilizers, are a class of psychotropic medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia but also in a range of other psychotic disorders.
See Rebound effect and Antipsychotic
Antipsychotic switching
Antipsychotic switching refers to the process of switching out one antipsychotic for another antipsychotic.
See Rebound effect and Antipsychotic switching
Anxiety
Anxiety is an emotion which is characterised by an unpleasant state of inner turmoil and includes feelings of dread over anticipated events.
See Rebound effect and Anxiety
Anxiolytic
An anxiolytic (also antipanic or anti-anxiety agent) is a medication or other intervention that reduces anxiety.
See Rebound effect and Anxiolytic
Benzodiazepine
Benzodiazepines (BZD, BDZ, BZs), colloquially called "benzos", are a class of depressant drugs whose core chemical structure is the fusion of a benzene ring and a diazepine ring.
See Rebound effect and Benzodiazepine
Benzodiazepine withdrawal syndrome
Benzodiazepine withdrawal syndrome (BZD withdrawal) is the cluster of signs and symptoms that may emerge when a person who has been taking benzodiazepines as prescribed develops a physical dependence on them and then reduces the dose or stops taking them without a safe taper schedule.
See Rebound effect and Benzodiazepine withdrawal syndrome
Clobetasol propionate
Clobetasol propionate is a corticosteroid used to treat skin conditions such as eczema, contact dermatitis, seborrheic dermatitis, and psoriasis.
See Rebound effect and Clobetasol propionate
Clonidine
Clonidine, sold under the brand name Catapres among others, is an α2A-adrenergic agonist medication used to treat high blood pressure, ADHD, drug withdrawal (alcohol, opioids, or nicotine), menopausal flushing, diarrhea, spasticity, and certain pain conditions.
See Rebound effect and Clonidine
Corticosteroid
Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones.
See Rebound effect and Corticosteroid
COVID-19
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2.
See Rebound effect and COVID-19
Dextroamphetamine
Dextroamphetamine (INN:dexamfetamine) is a potent central nervous system (CNS) stimulant and enantiomer of amphetamine that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.
See Rebound effect and Dextroamphetamine
Disuse supersensitivity
Disuse supersensitivity, also pharmacological disuse supersensitivity or pharmacological denervation supersensitivity, is the increased sensitivity by a postsynaptic cell because of decreased input by incoming axons, e.g., due to the exposure to an antagonist drug.
See Rebound effect and Disuse supersensitivity
Dopamine supersensitivity psychosis
Dopamine supersensitivity psychosis is a hypothesis that attempts to explain the phenomenon in which psychosis (e.g. having hallucinations, which can mean hearing or seeing things that other people do not see or hear) occurs despite treatment with escalating doses of antipsychotics.
See Rebound effect and Dopamine supersensitivity psychosis
Drug withdrawal
Drug withdrawal, drug withdrawal syndrome, or substance withdrawal syndrome, is the group of symptoms that occur upon the abrupt discontinuation or decrease in the intake of pharmaceutical or recreational drugs.
See Rebound effect and Drug withdrawal
Eszopiclone
Eszopiclone, sold under the brand name Lunesta among others, is a medication used in the treatment of insomnia.
See Rebound effect and Eszopiclone
Guanfacine
Guanfacine, sold under the brand name Tenex (immediate-release) and Intuniv (extended-release) among others, is an oral alpha-2a agonist medication used to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure.
See Rebound effect and Guanfacine
Hypnotic
Hypnotic (from Greek Hypnos, sleep), or soporific drugs, commonly known as sleeping pills, are a class of (and umbrella term for) psychoactive drugs whose primary function is to induce sleep (or surgical anesthesiaWhen used in anesthesia to produce and maintain unconsciousness, "sleep" is metaphorical as there are no regular sleep stages or cyclical natural states; patients rarely recover from anesthesia feeling refreshed and with renewed energy.
See Rebound effect and Hypnotic
Insomnia
Insomnia, also known as sleeplessness, is a sleep disorder where people have trouble sleeping.
See Rebound effect and Insomnia
Joe Biden
Joseph Robinette Biden Jr. (born November 20, 1942) is an American politician who is the 46th and current president of the United States since 2021.
See Rebound effect and Joe Biden
Major depressive disorder
Major depressive disorder (MDD), also known as clinical depression, is a mental disorder characterized by at least two weeks of pervasive low mood, low self-esteem, and loss of interest or pleasure in normally enjoyable activities.
See Rebound effect and Major depressive disorder
Medication
A medication (also called medicament, medicine, pharmaceutical drug, medicinal drug or simply drug) is a drug used to diagnose, cure, treat, or prevent disease.
See Rebound effect and Medication
Medication overuse headache
A medication overuse headache (MOH), also known as a rebound headache, usually occurs when painkillers are taken frequently to relieve headaches.
See Rebound effect and Medication overuse headache
Methylphenidate
Methylphenidate, sold under the brand names Ritalin and Concerta among others, is a potent central nervous system (CNS) stimulant used medically to treat attention deficit hyperactivity disorder (ADHD) and, to a lesser extent, narcolepsy.
See Rebound effect and Methylphenidate
Nasal congestion
Nasal congestion is the partial or complete blockage of nasal passages, leading to impaired nasal breathing, usually due to membranes lining the nose becoming swollen from inflammation of blood vessels.
See Rebound effect and Nasal congestion
Nasal spray
Nasal sprays are used to deliver medications locally in the nasal cavities or systemically.
See Rebound effect and Nasal spray
Nirmatrelvir/ritonavir
Nirmatrelvir/ritonavir, sold under the brand name Paxlovid, is a co-packaged medication used as a treatment for COVIDnbhyph19.
See Rebound effect and Nirmatrelvir/ritonavir
Panic attack
Panic attacks are sudden periods of intense fear and discomfort that may include palpitations, sweating, chest pain or chest discomfort, shortness of breath, trembling, dizziness, numbness, confusion, or a feeling of impending doom or of losing control.
See Rebound effect and Panic attack
Physical dependence
Physical dependence is a physical condition caused by chronic use of a tolerance-forming drug, in which abrupt or gradual drug withdrawal causes unpleasant physical symptoms.
See Rebound effect and Physical dependence
Psoriasis
Psoriasis is a long-lasting, noncontagious autoimmune disease characterized by patches of abnormal skin.
See Rebound effect and Psoriasis
Quazepam
Quazepam, sold under brand name Doral among others, is a relatively long-acting benzodiazepine derivative drug developed by the Schering Corporation in the 1970s.
See Rebound effect and Quazepam
Rhinitis medicamentosa
Rhinitis medicamentosa (or RM, also known as rebound congestion) is a condition of rebound nasal congestion suspected to be brought on by extended use of topical decongestants (e.g., oxymetazoline, phenylephrine, xylometazoline, and naphazoline nasal sprays) and certain oral medications (e.g., sympathomimetic amines and various 2-imidazolines) that constrict blood vessels in the lining of the nose, although evidence has been contradictory.
See Rebound effect and Rhinitis medicamentosa
Sedative
A sedative or tranquilliser is a substance that induces sedation by reducing irritability or excitement.
See Rebound effect and Sedative
Selective serotonin reuptake inhibitor
Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder, anxiety disorders, and other psychological conditions.
See Rebound effect and Selective serotonin reuptake inhibitor
Signs and symptoms
Signs and symptoms are the observed or detectable signs, and experienced symptoms of an illness, injury, or condition.
See Rebound effect and Signs and symptoms
Stimulant
Stimulants (also known as central nervous system stimulants, or psychostimulants, or colloquially as uppers) are a class of drugs that increase the activity of the brain.
See Rebound effect and Stimulant
Stimulant psychosis
Stimulant psychosis is a mental disorder characterized by psychotic symptoms (such as hallucinations, paranoid ideation, delusions, disorganized thinking, grossly disorganized behaviour).
See Rebound effect and Stimulant psychosis
Topical decongestant
Topical decongestants are decongestants applied directly to the nasal cavity.
See Rebound effect and Topical decongestant
Triazolam
Triazolam, sold under the brand name Halcion among others, is a central nervous system (CNS) depressant tranquilizer of the triazolobenzodiazepine (TBZD) class, which are benzodiazepine (BZD) derivatives.
See Rebound effect and Triazolam
Unintended consequences
In the social sciences, unintended consequences (sometimes unanticipated consequences or unforeseen consequences, more colloquially called knock-on effects) are outcomes of a purposeful action that are not intended or foreseen.
See Rebound effect and Unintended consequences
Zolpidem
Zolpidem, sold under the brand name Ambien among others, is a medication primarily used for the short-term treatment of sleeping problems.
See Rebound effect and Zolpidem
See also
Psychiatric diagnosis
- Cynanthropy
- Diagnostic and Statistical Manual of Mental Disorders
- Labeling theory
- Primary and secondary gain
- Psychiatric assessment
- Rebound effect
- Wastebasket diagnosis
References
[1] https://en.wikipedia.org/wiki/Rebound_effect
Also known as Double rebound, Drug rebound, Rebound Covid, Rebound activity, Rebound anxiety, Rebound depression, Rebound effects, Rebound insomnia, Rebound phenomenon, Rebound psychosis, Rebound reactions, Rebound symptoms, Rebound syndrome, Rebound withdrawal, Rebound withdrawal effects.